201 related articles for article (PubMed ID: 37085539)
21. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
[TBL] [Abstract][Full Text] [Related]
22. C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma.
Zhu JJ; Jillette N; Li XN; Cheng AW; Lau CC
Acta Neuropathol; 2020 Dec; 140(6):951-960. PubMed ID: 32909151
[TBL] [Abstract][Full Text] [Related]
23. Characterization of 2 Novel Ependymoma Cell Lines With Chromosome 1q Gain Derived From Posterior Fossa Tumors of Childhood.
Amani V; Donson AM; Lummus SC; Prince EW; Griesinger AM; Witt DA; Hankinson TC; Handler MH; Dorris K; Vibhakar R; Foreman NK; Hoffman LM
J Neuropathol Exp Neurol; 2017 Jul; 76(7):595-604. PubMed ID: 28863455
[TBL] [Abstract][Full Text] [Related]
24. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.
Cachia D; Wani K; Penas-Prado M; Olar A; McCutcheon IE; Benjamin RS; Armstrong TS; Gilbert MR; Aldape KD
Brain Tumor Pathol; 2015 Apr; 32(2):105-11. PubMed ID: 25388523
[TBL] [Abstract][Full Text] [Related]
25. ZFTA-YAP1 fusion-positive ependymoma can occur in the spinal cord: Letter to the editor.
Lim KY; Lee KH; Phi JH; Yun H; Won JK; Choi SH; Park SH
Brain Pathol; 2022 Jan; 32(1):e13020. PubMed ID: 34506076
[TBL] [Abstract][Full Text] [Related]
26. Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ; Ghasemi DR; Andreiuolo F; Zschernack V; Espariat AT; Buttarelli FR; Giangaspero F; Grill J; Haberler C; Paine SML; Scott I; Jacques TS; Sill M; Pfister S; Kilday JP; Leblond P; Massimino M; Witt H; Modena P; Varlet P; Pietsch T; Grundy RG; Pajtler KW; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1871-1882. PubMed ID: 36916248
[TBL] [Abstract][Full Text] [Related]
27. Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features.
Andreiuolo F; Varlet P; Tauziède-Espariat A; Jünger ST; Dörner E; Dreschmann V; Kuchelmeister K; Waha A; Haberler C; Slavc I; Corbacioglu S; Riemenschneider MJ; Leipold A; Rüdiger T; Körholz D; Acker T; Russo A; Faber J; Sommer C; Armbrust S; Rose M; Erdlenbruch B; Hans VH; Bernbeck B; Schneider D; Lorenzen J; Ebinger M; Handgretinger R; Neumann M; van Buiren M; Prinz M; Roganovic J; Jakovcevic A; Park SH; Grill J; Puget S; Messing-Jünger M; Reinhard H; Bergmann M; Hattingen E; Pietsch T
Brain Pathol; 2019 Mar; 29(2):205-216. PubMed ID: 30246434
[TBL] [Abstract][Full Text] [Related]
28. Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders.
Uusküla-Reimand L; Hou H; Samavarchi-Tehrani P; Rudan MV; Liang M; Medina-Rivera A; Mohammed H; Schmidt D; Schwalie P; Young EJ; Reimand J; Hadjur S; Gingras AC; Wilson MD
Genome Biol; 2016 Aug; 17(1):182. PubMed ID: 27582050
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation in transposable elements buffers the connection between three-dimensional chromatin organization and gene transcription upon rice genome duplication.
Sun Z; Wang Y; Song Z; Zhang H; Wang Y; Liu K; Ma M; Wang P; Fang Y; Cai D; Li G; Fang Y
J Adv Res; 2022 Dec; 42():41-53. PubMed ID: 35933090
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract][Full Text] [Related]
31. Modelling genome-wide topological associating domains in mouse embryonic stem cells.
Zhan Y; Giorgetti L; Tiana G
Chromosome Res; 2017 Mar; 25(1):5-14. PubMed ID: 28108933
[TBL] [Abstract][Full Text] [Related]
32. The nuclear matrix protein HNRNPU maintains 3D genome architecture globally in mouse hepatocytes.
Fan H; Lv P; Huo X; Wu J; Wang Q; Cheng L; Liu Y; Tang QQ; Zhang L; Zhang F; Zheng X; Wu H; Wen B
Genome Res; 2018 Feb; 28(2):192-202. PubMed ID: 29273625
[TBL] [Abstract][Full Text] [Related]
33. Principles of Chromosome Architecture Revealed by Hi-C.
Eagen KP
Trends Biochem Sci; 2018 Jun; 43(6):469-478. PubMed ID: 29685368
[TBL] [Abstract][Full Text] [Related]
34. Molecular subgrouping of ependymoma across three anatomic sites and their prognostic implications.
Chinnam D; Gupta K; Kiran T; Saraswati A; Salunke P; Madan R; Kumar N; Radotra BD
Brain Tumor Pathol; 2022 Jul; 39(3):151-161. PubMed ID: 35348910
[TBL] [Abstract][Full Text] [Related]
35. [Precision Medicine for Ependymoma].
Gomi A
No Shinkei Geka; 2022 Jan; 50(1):91-100. PubMed ID: 35169089
[TBL] [Abstract][Full Text] [Related]
36. Exploring the 2D and 3D structural properties of topologically associating domains.
Liu T; Wang Z
BMC Bioinformatics; 2019 Dec; 20(Suppl 16):592. PubMed ID: 31787081
[TBL] [Abstract][Full Text] [Related]
37. The macro and micro of chromosome conformation capture.
Goel VY; Hansen AS
Wiley Interdiscip Rev Dev Biol; 2021 Nov; 10(6):e395. PubMed ID: 32987449
[TBL] [Abstract][Full Text] [Related]
38. Improved risk-stratification for posterior fossa ependymoma of childhood considering clinical, histological and genetic features - a retrospective analysis of the HIT ependymoma trial cohort.
Jünger ST; Mynarek M; Wohlers I; Dörner E; Mühlen AZ; Velez-Char N; von Hoff K; Rutkowski S; Warmuth-Metz M; Kortmann RD; Timmermann B; Rahmann S; Klein-Hitpass L; von Bueren AO; Pietsch T
Acta Neuropathol Commun; 2019 Nov; 7(1):181. PubMed ID: 31727173
[TBL] [Abstract][Full Text] [Related]
39. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.
Peyre M; Commo F; Dantas-Barbosa C; Andreiuolo F; Puget S; Lacroix L; Drusch F; Scott V; Varlet P; Mauguen A; Dessen P; Lazar V; Vassal G; Grill J
PLoS One; 2010 Sep; 5(9):e12932. PubMed ID: 20885975
[TBL] [Abstract][Full Text] [Related]
40. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]